MACK logo

MACK Depreciation And Amortization

MACK Annual D&A

N/A

31 December 2023

All-time High

$5.22 M
MACK annual depreciation & amortization is currently at an all-time high
Annual Total Expenses$2.18 M
MACK annual total expenses is $2.18 million
Annual Operating Expenses$2.18 M
MACK annual total operating expenses is $2.18 million
Annual Net Income-$1.18 M
MACK annual net profit is -$1.18 million

MACK Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MACK Quarterly D&A

N/A

01 March 2024

All-time High

$2.41 M
MACK quarterly depreciation & amortization is currently at an all-time high
Quarterly Total Expenses$669.00 K
MACK quarterly total expenses is $669.00 thousand
Quarterly Operating Expenses$669.00 K
MACK quarterly total operating expenses is $669.00 thousand
Quarterly Net Income$201.37 M
MACK quarterly net profit is $201.37 million

MACK Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MACK TTM D&A

N/A

01 March 2024

All-time High

$5.62 M
MACK TTM depreciation & amortization is currently at an all-time high
Annual Total Expenses$2.18 M
MACK annual total expenses is $2.18 million
Annual Operating Expenses$2.18 M
MACK annual total operating expenses is $2.18 million
TTM Net Income$200.46 M
MACK TTM net profit is $200.46 million

MACK TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MACK Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

MACK Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Merrimack Pharmaceuticals Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2019
$2.23 M(-45.3%)
$0.00(0.0%)
$2.23 M(-27.9%)
Sept 2019
-
$0.00(-100.0%)
$3.09 M(-23.6%)
June 2019
-
$1.01 M(-17.2%)
$4.04 M(-0.2%)
Mar 2019
-
$1.22 M(+41.3%)
$4.05 M(-0.5%)
Dec 2018
$4.07 M(-22.0%)
$863.00 K(-9.4%)
$4.07 M(-27.5%)
Sept 2018
-
$953.00 K(-6.5%)
$5.62 M(+3.7%)
June 2018
-
$1.02 M(-17.8%)
$5.42 M(+2.7%)
Mar 2018
-
$1.24 M(-48.5%)
$5.28 M(+1.1%)
Dec 2017
$5.22 M(+6.7%)
$2.41 M(+218.9%)
$5.22 M(+48.0%)
Sept 2017
-
$755.00 K(-13.8%)
$3.53 M(-23.7%)
June 2017
-
$876.00 K(-25.9%)
$4.62 M(-5.3%)
Mar 2017
-
$1.18 M(+65.5%)
$4.88 M(-0.3%)
Dec 2016
$4.89 M(+50.6%)
$714.00 K(-61.4%)
$4.89 M(+57.3%)
Sept 2016
-
$1.85 M(+62.8%)
$3.11 M(-10.9%)
June 2016
-
$1.14 M(-5.3%)
$3.49 M(+2.9%)
Mar 2016
-
$1.20 M(-212.0%)
$3.39 M(+4.4%)
Dec 2015
$3.25 M(+0.8%)
-$1.07 M(-148.0%)
$3.25 M(-31.3%)
Sept 2015
-
$2.23 M(+114.6%)
$4.73 M(+53.9%)
June 2015
-
$1.04 M(-1.5%)
$3.07 M(-9.3%)
Mar 2015
-
$1.05 M(+155.8%)
$3.39 M(+5.2%)
DateAnnualQuarterlyTTM
Dec 2014
$3.22 M(+24.5%)
$412.00 K(-27.7%)
$3.22 M(-7.2%)
Sept 2014
-
$570.00 K(-57.9%)
$3.47 M(-1.1%)
June 2014
-
$1.35 M(+52.9%)
$3.51 M(+26.5%)
Mar 2014
-
$886.00 K(+33.6%)
$2.77 M(+7.2%)
Dec 2013
$2.59 M(-29.3%)
$663.00 K(+9.2%)
$2.59 M(-2.2%)
Sept 2013
-
$607.00 K(-1.9%)
$2.65 M(-2.7%)
June 2013
-
$619.00 K(-11.6%)
$2.72 M(-14.0%)
Mar 2013
-
$700.00 K(-2.9%)
$3.16 M(-13.7%)
Dec 2012
$3.66 M(-20.3%)
$721.00 K(+6.0%)
$3.66 M(+4.4%)
Sept 2012
-
$680.00 K(-36.0%)
$3.51 M(-16.2%)
June 2012
-
$1.06 M(-11.6%)
$4.19 M(-6.5%)
Mar 2012
-
$1.20 M(+111.8%)
$4.48 M(-2.5%)
Dec 2011
$4.60 M(+26.7%)
$567.00 K(-58.3%)
$4.60 M(-0.9%)
Sept 2011
-
$1.36 M(+0.4%)
$4.64 M(+5.7%)
June 2011
-
$1.35 M(+2.9%)
$4.39 M(+10.7%)
Mar 2011
-
$1.32 M(+116.1%)
$3.96 M(+9.3%)
Dec 2010
$3.63 M(+31.7%)
$609.00 K(-45.0%)
$3.63 M(+20.2%)
Sept 2010
-
$1.11 M(+19.0%)
$3.02 M(+58.0%)
June 2010
-
$931.00 K(-5.0%)
$1.91 M(+95.0%)
Mar 2010
-
$980.00 K
$980.00 K
Dec 2009
$2.75 M
-
-

FAQ

  • What is the all time high annual D&A for Merrimack Pharmaceuticals?
  • What is the all time high quarterly D&A for Merrimack Pharmaceuticals?
  • What is the all time high TTM D&A for Merrimack Pharmaceuticals?

What is the all time high annual D&A for Merrimack Pharmaceuticals?

Merrimack Pharmaceuticals all-time high annual depreciation & amortization is $5.22 M

What is the all time high quarterly D&A for Merrimack Pharmaceuticals?

Merrimack Pharmaceuticals all-time high quarterly depreciation & amortization is $2.41 M

What is the all time high TTM D&A for Merrimack Pharmaceuticals?

Merrimack Pharmaceuticals all-time high TTM depreciation & amortization is $5.62 M